首页 | 本学科首页   官方微博 | 高级检索  
     

不同硫代修饰CpG ODN佐剂活性的比较
引用本文:屈旭成,何鹏,邱少辉,方鑫,童海青,葛君,李建强,姜崴,胡忠玉.不同硫代修饰CpG ODN佐剂活性的比较[J].粉末涂料与涂装,2020(1):19-25.
作者姓名:屈旭成  何鹏  邱少辉  方鑫  童海青  葛君  李建强  姜崴  胡忠玉
作者单位:;1.中国食品药品检定研究院卫生部生物技术产品检定方法及其标准化重点实验室;2.长春生物制品研究所有限责任公司;3.安徽龙科马生物制药有限责任公司;4.南京远大赛威信生物医药有限公司
基金项目:国家“十三五”新药创制科技重大专项“创新生物技术药评价及标准化关键技术研究”(2018zx09101001)
摘    要:目的评价相同序列不同硫代修饰CpG ODN佐剂联合重组乙型肝炎疫苗表面抗原(rHBsAg)在BALB/c小鼠中的免疫原性,及在HEK-BlueTM hTLR9细胞上的活性。方法将4种(全硫代修饰的QCX1、部分硫代修饰的HS1和HS2及非硫代修饰的NS)CpG ODN及其阳性对照(全硫代修饰的CpG7909)按照相同配比分别与rHBsAg混合,使CpG ODN和rHBsAg终浓度均为20μg/mL,同时设等剂量抗原对照组(rHBsAg)及空白对照组(生理盐水)。分别肌肉免疫BALB/c小鼠,每只100μL,于免疫后1、2、4周摘眼球采血后处死小鼠,分离血清,应用化学发光微粒子免疫分析技术检测乙型肝炎病毒表面抗体(antibody to hepatitis B virus surface antigen,Anti-HBs)水平;取小鼠脾脏,制备脾细胞悬液,分离脾单个核细胞(mononuclear cell,MNCs),应用ELISPOT技术检测抗原特异性IFNγ、IL-2的分泌水平。体外应用HEK-BlueTM hTLR9细胞,检测4种CpG ODN及阳性对照CpG7909在该细胞上的活性,以及血清中放置不同时间后在该细胞上的活性。结果免疫后1、2、4周,各组小鼠血清Anti-HBs水平逐渐升高,其中免后2、4周,QCX1组小鼠血清抗体水平高于抗原对照、HS1、HS2、NS组;QCX1组小鼠MNCs在rHBsAg刺激下,分泌IFNγ和IL-2的能力显著高于HS1、HS2、NS和抗原对照组(P均<0.01);QCX1和HS2组刺激HEK-BlueTM hTLR9细胞活性的半数有效浓度(EC50)分别为5.94和6.52μg/mL,明显低于HS1(46.54μg/mL)和NS组(49.10μg/mL);随着不同硫代修饰CpG ODN在血清中放置时间的延长,仅全硫代修饰QCX1和CpG7909组细胞培养物A655基本不变,其他组均出现不同程度降低。结论全硫代修饰组QCX1佐剂增强小鼠细胞和体液免疫的能力与CpG7909相当,且在HEK-BlueTM hTLR9细胞上呈现较好的活性,在血清中也具有较好的稳定性。

关 键 词:CpG  ODN  佐剂  硫代修饰  乙型肝炎疫苗  活性

Comparison of adjuvant activities of different phosphorothioate backbone modified CpG ODN
QU Xu-cheng,HE Peng,QIU Shao-hui,FANG Xin,TONG Hai-qing,GE Jun,LI Jian-qiang,JIANG Wei,HU Zhong-yu.Comparison of adjuvant activities of different phosphorothioate backbone modified CpG ODN[J].Chinese Journal of Biologicals,2020(1):19-25.
Authors:QU Xu-cheng  HE Peng  QIU Shao-hui  FANG Xin  TONG Hai-qing  GE Jun  LI Jian-qiang  JIANG Wei  HU Zhong-yu
Affiliation:(National Institutes for Food and Drug Control,Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,Beijing 102629,China)
Abstract:Objective To evaluate the immunogenicity of different phosphorothioate modified CpG ODN adjuvant combined with recombinant hepatitis B surface antigen(rHBsAg)in BALB/c mice and their activities in HEK-BlueTM hTLR9 cells.Methods Four kinds of CpG ODNs(completely phosphorothioate modified QCX1,partially phosphorothioate modified HS1,partially phosphorothioate modified HS2 and NS without phosphorothioate modification)and positive control(completely phosphorothioate modified CpG7909)were mixed with rHBsAg at the same proportions,in which the final concentrations of CpG ODN and rHBsAg were both 20μg/mL,while rHBsAg at the same dosage was set up as antigen control group,and physiological saline as blank control,with which BALB/c mice were immunized intramuscularly,100μL for each.Serum samples were collected 1,2 and 4 weeks after immunization and determined for antibody to HBsAg(Anti-HBs)by chemiluminesent microparticle immunoassay kit.Meanwhile,the spleen cell suspension of mice was prepared,from which spleen mononuclear cells(MNCs)were isolated and determined for the secretion levels of antigen-specific IFNγand IL-2 by enzyme linked immunospot assay(ELISPOT).The activities of four kinds of CpG ODN and positive control CpG7909 in HEK-BlueTM hTLR9 cells,as well as the activities after storage in sera for various days,were determined in vitro.Results The anti-HBs levels in sera of mice in various groups increased gradually 1,2 and 4 weeks after immunization,while those in QCX1 group 2 and 4 weeks after immunization were higher than those in rHBsAg control,HS1,HS2 and NS groups.The ability of MNCs stimulated by rHBsAg in QCX1 group in secreting IFNγand IL-2 was significantly higher than those in HS1,HS2,NS and rHBsAg control groups(each P<0.01).The half effective concentrations(EC50)for stimulation of HEK-BlueTM hTLR9 cell activity in QCX1 and HS2 groups were 5.94 and 6.52μg/mL respectively,which were significantly lower than those in HS1(46.54μg/mL)and NS(49.10μg/mL)groups.With the increasing time for storage of CpG ODN in sera,only the A655 values of cell cultures in QCX1 and CpG7909 groups showed little change,while those in other groups decreased at different degrees.Conclusion The completely phosphorothioate modified QCX1 adjuvant was equivalent to CpG 7909 in enhancing the cellular and humoral immunities of mice,which showed high activity in HEK-BlueTM hTLR9 and high stability in sera.
Keywords:CpG ODN  Adjuvant  Phosphorothioate modification  Hepatitis B vaccine  Activity
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号